RUSSELL ROSS: Open Payments
NPI 1619526761 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,255 in 84 payments from 23 companies in 2025. Trend: 2023 $829 · 2024 $1,460 · 2025 $1,255
Food & beverage: $1,255
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 17 | $233 |
| Bayer Healthcare Pharmaceuticals Inc. | 25 | $215 |
| ABBVIE INC. | 11 | $208 |
| Novo Nordisk Inc | 5 | $89 |
| Lilly USA, LLC | 4 | $66 |
| Amgen Inc. | 3 | $50 |
| ALK-Abello, Inc | 1 | $35 |
| Exact Sciences Corporation | 2 | $34 |
| Corium, LLC | 1 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $30 |
Products named: Kerendia, NURTEC ODT, QULIPTA, Wegovy, MOUNJARO, UBRELVY, ELIQUIS, OTEZLA.
Industry payments across TX — which companies pay providers there.
